Rad6 is a Potential Early Marker of Melanoma Development.


Melanoma is the leading cause of death from skin cancer in industrialized countries. Several melanoma-related biomarkers and signaling pathways have been identified; however, their relevance to melanoma development/progression or to clinical outcome remains to be established. Aberrant activation of Wnt/β-catenin pathway is implicated in various cancers… (More)
DOI: 10.1016/j.tranon.2014.04.009


5 Figures and Tables

Cite this paper

@article{Rosner2014Rad6IA, title={Rad6 is a Potential Early Marker of Melanoma Development.}, author={Karli Rosner and Shreelekha Adsule and Brittany Haynes and Evangelia Kirou and Ikuko Kato and Darius Mehregan and Malathy P V Shekhar}, journal={Translational oncology}, year={2014} }